Correspondence on “Changes in memory and cognition during the SARS-CoV-2 human challenge study”
Raffaella Ravinetto +4 more
doaj +1 more source
Modernizing the Institutional Review Board Process for Implementation Science - A Narrative Review of Barriers and Ethical Considerations. [PDF]
Bazaz A +9 more
europepmc +1 more source
State Personnel Board of Review annual report
Electronic coverage as of Feb.
Ohio. State Personnel Board of Review. +1 more
core
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro +14 more
wiley +1 more source
Institutional Review Board Obligations Regarding Study Funding Sufficiency. [PDF]
Lynch HF, Mohammad T.
europepmc +1 more source
Clinical Use of Extracellular Vesicles in the Management of Male and Female Pattern Hair Loss: A Preliminary Retrospective Institutional Review Board Safety and Efficacy Study. [PDF]
Sasaki GH.
europepmc +1 more source
T1 Over Squared Proton Density Ratio to Characterize Multiple Sclerosis Lesions
ABSTRACT Objective Differentiating remyelinated from demyelinated lesions in MS remains challenging without histological confirmation. This study introduces the T1‐to‐PD2 ratio (TPR) imaging approach and evaluates its ability to characterize MS lesions alongside other quantitative MRI (qMRI) metrics. Methods Thirty individuals with MS (mean age: 47.5 ±
Sarah J. Wright +10 more
wiley +1 more source
Institutional Review Board Approval of Plastic Surgery Studies: Why It Matters. [PDF]
Swanson E.
europepmc +1 more source
Community Member's Perspective: Serving on an Institutional Review Board. [PDF]
Butcher BT.
europepmc +1 more source
ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes +75 more
wiley +1 more source

